JAK2 phosphorylation (using a JAK2 Y1007/Y1008 phospho-specific antibody), TEL-JAK2 (using a TEL antibody) and STAT5 Y694 phosphorylation. C, MHH-CALL-4 cells were treated for 1 h either with DMSO or with 1 μM NVP-BBT594 and then extracted for Western blot detection of JAK2 Y1007/Y1008 phosphorylation and STAT5 Y694 phosphorylation.
Total levels of JAK2 and STAT5 were probed for as loading controls. D, TF-1 cells were starved in medium without GM-CSF for 4 h and then either pre-treated with DMSO or 1 μM NVP-BBT594 for 1 h. Cells were then stimulated or not with 20 ng/ml IFN-α for 10 minutes, 
Supplementary Table Legends
Supplementary Table S1 . Activity of NVP-BBT594 in biochemical and cell-based assays.
The IC 50 (mean of two experiments) of NVP-BBT594 on the JAK2 kinase was determined in a biochemical kinase assay with the active enzyme (1). Half-maximal growth inhibition (GI 50 ,) of NVP-BBT594 was determined in SET-2, CMK and K-562 cell lines (mean ± SD, n = 4). Supplementary Table S3 . X-ray crystallographic data collection and refinement statistics. Diffraction data were collected at the Swiss Light Source (beamline X10SA). Raw diffraction data were processed and scaled with the XDS/XSCALE software package. The program BUSTER was used for structure refinement using all diffraction data between 20 and 1.34 Å resolution, excluding 5% of the data for cross-validation.
Supplementary

Supplementary Methods
RNA interference
JAKs were depleted using the following stealth™ RNAi oligonucleotides (Invitrogen, 
Generation of Ba/F3 cell lines stably expressing MPL W515L , EpoR and TEL-JAK2
were determined from progress curves of the JAK2 kinase reaction. The inhibited reaction was described by pseudo first-order kinetics according to the equation 
The rate of the inhibited reaction at steady-state is related to K i by the equation (6) (eq. 5)
By replacing k obs (eq. 3 or eq. 4) and v S (eq. 5) in eq. 1 the following equations are obtained:
Progress curves obtained in the presence of different concentrations of inhibitor in at least two independent experiments were combined and fitted as a whole by using eq. 6 and eq. 7 in a 3D fit with t and [I] as the independent variables. Nonlinear regression was performed with (Supplementary Fig. S3 ).
Purification of tyrosine-phosphorylated peptides
SET - and peptide identifications accepted which exceeded the 95% confidence level. In case of ambiguous assignments, spectra were manually interpreted for confirmation of identity and localization of the phosphorylation site. Label free quantification was performed on duplicate LC-MS runs for each sample using Progenesis LC-MS (Nonlinear Dynamics Software).
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